Key terms

About ADVM

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ADVM news

Mar 27 9:50pm ET Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM) by TipRanks Mar 25 10:30pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 21 5:26pm ET Adverum Biotechnologies files $200M mixed securities shelf by TipRanks Mar 21 2:46am ET Positive Outlook for Adverum Biotechnologies with Upcoming Ixo-vec Milestones and Strong Financial Position by TipRanks Mar 20 7:50pm ET Adverum Biotechnologies trading halted, news pending by TipRanks Mar 20 2:00am ET Brexit Uncertainty: Navigating New Risks and Regulatory Hurdles for Adverum Biotechnologies by TipRanks Mar 19 7:20am ET Adverum Biotechnologies price target lowered to $2 from $3 at RBC Capital by TipRanks Mar 19 6:45am ET Adverum Biotechnologies (ADVM) Initiated with a Hold at RBC Capital by TipRanks Mar 18 5:55pm ET Adverum Biotechnologies (ADVM) Receives a Buy from TD Cowen by TipRanks Mar 18 4:13pm ET Adverum Biotechnologies reports Q4 EPS (23c), consensus (34c) by TipRanks Mar 04 4:42pm ET Adverum Biotechnologies files to sell 106.48M shares of common stock for holders by TipRanks Feb 09 4:20am ET Adverum’s Ixoberogene Soroparvovec Shows Promise in LUNA Trial by TipRanks Feb 08 11:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 08 7:05am ET Adverum Biotechnologies announces efficacy, safety data from LUNA Phase 2 trial by TipRanks Feb 07 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 07 5:07am ET Adverum Biotechnologies Awaits Court Decision on Settlement by TipRanks Feb 06 6:38am ET Adverum Biotechnologies price target raised to $4 from $2 at Mizuho by TipRanks Feb 06 5:03am ET Adverum Biotechnologies Executes Private Equity Placement by TipRanks Feb 06 5:02am ET Adverum Biotechnologies Secures $127.8M in Private Placement by TipRanks Feb 05 10:51am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 05 7:47am ET Adverum Biotechnologies to sell 106.25M shares at $1.20 in private placement by TipRanks Feb 05 4:50am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW) by TipRanks

No recent news articles are available for ADVM

No recent press releases are available for ADVM

ADVM Financials

1-year income & revenue

Key terms

ADVM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ADVM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’